A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)
Clinical trial NCT04339413 · TERMINATED
Trial details
- NCT number
- NCT04339413
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2023-01-04
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.